Skip to main content
. 2021 May 14;10(11):3635–3645. doi: 10.1002/cam4.3921

FIGURE 4.

FIGURE 4

Cumulative incidence of second major molecular response, MR4 log and MR4.5 log after TKI resumption in patients experienced molecular recurrence after TKI stop (N = 43 pts)